CONNECT WITH US
HealthTech

HealthTech

Most patients won't endorse AI medical responses without a clinician's review, study finds

Medical Xpress logo

Published on

Add as a preferred source on Google
Most patients won't endorse AI medical responses without a clinician's review, study finds

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

In a Columbia University School of Nursing study surveying 1,185 U.S.-based adults about AI use in secure medical portals, 63% of patients said they would not endorse AI-generated medical responses without a clinician's review. This suggests that while patients see value in using AI for certain health care tasks, they prefer a human review when medical advice is involved. The study, "Public Perceptions of Timeliness for AI Use and Human Oversight," was published in the JAMA Network Open on Oct. 14, 2026.

Researchers found that patients' preferences differed by task. Most respondents preferred fast AI-generated responses for logistical requests such as appointment scheduling and prescription refills (57%). However, two-thirds of participants said they would rather wait up to 48 hours for a doctor or nurse to review and edit an AI response to medical questions.

The researchers also examined attitudes around mental health support using AI. Participants said they most likely would use a licensed human therapist, even with a three-month wait (64%). Acceptance declined for a therapist-monitored AI chatbot available within one month (50%) and an AI-only chatbot available immediately (44%).

"This study showed what we had already assumed but can now back up with data. , lead author and assistant professor at Columbia Nursing.



Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.